Note 21—Investments in Group Enterprises and Associates Ascendis Pharma A/S’s (parent company) investments in group enterprises and associates at December 31, 2025 comprise:
|
|
|
|
|
|
|
Subsidiaries |
|
Domicile |
|
Ownership |
|
Ascendis Pharma GmbH |
|
Germany |
|
|
100 |
% |
Ascendis Pharma Endocrinology GmbH |
|
Germany |
|
|
100 |
% |
Ascendis Pharma, LLC |
|
USA |
|
|
100 |
% |
Ascendis Pharma Endocrinology, Inc. |
|
USA |
|
|
100 |
% |
Ascendis Pharma, Ophthalmology Division A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma Endocrinology Division A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma Bone Diseases A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma Growth Disorders A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma Oncology Division A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma Europe A/S |
|
Denmark |
|
|
100 |
% |
Ascendis Pharma UK Limited |
|
United Kingdom |
|
|
100 |
% |
Ascendis Pharma Iberia S.L. |
|
Spain |
|
|
100 |
% |
Ascendis Pharma France SASU |
|
France |
|
|
100 |
% |
Ascendis Pharma Italia S.R.L. |
|
Italy |
|
|
100 |
% |
Ascendis Pharma Sverige AB |
|
Sweden |
|
|
100 |
% |
Ascendis Pharma Switzerland GmbH |
|
Switzerland |
|
|
100 |
% |
Ascendis Pharma Belgium BV |
|
Belgium |
|
|
100 |
% |
ASND Portugal, Unipessoal, Lda. |
|
Portugal |
|
|
100 |
% |
|
|
|
|
|
|
Associates |
|
Domicile |
|
Ownership |
|
VISEN Pharmaceuticals |
|
Cayman Island |
|
|
39.2 |
% |
Eyconis Inc. |
|
USA |
|
|
33.2 |
% |
|